Arylsulfatase C

Arylsulfatase C, also known as steroid sulfatase (STS), is an enzyme that in humans is encoded by the STS gene located on the X chromosome. This enzyme plays a crucial role in the metabolism of steroids, specifically in the desulfation of steroid sulfates, a process pivotal for the synthesis of active steroids in the body. Arylsulfatase C is involved in the metabolism of estrogen, testosterone, and DHEA (dehydroepiandrosterone), making it essential for the proper functioning of various physiological processes, including hormone regulation, reproduction, and development.

Function

Arylsulfatase C functions by catalyzing the hydrolysis of sulfate esters from steroid sulfates, thus converting these inactive forms into their active hormone counterparts. This enzymatic activity is critical for the regulation of hormone availability and action in target tissues. The enzyme's activity is particularly important in tissues that rely on the local conversion of sulfated to free, active hormones, such as in the placenta, breast, skin, and brain.

Genetics

The STS gene, which encodes the arylsulfatase C enzyme, is located on the X chromosome (Xp22.31). Mutations in this gene can lead to a deficiency in the enzyme, resulting in multiple metabolic disorders. One of the most well-known conditions associated with mutations in the STS gene is X-linked ichthyosis, a disorder characterized by the accumulation of scales on the skin due to defective desquamation.

Clinical Significance

A deficiency in arylsulfatase C activity can lead to several clinical conditions, including the aforementioned X-linked ichthyosis. This condition is marked by the accumulation of cholesterol sulfate due to the reduced ability to convert sulfated steroids into their active forms, leading to skin abnormalities. Additionally, variations in the activity of this enzyme have been implicated in hormone-dependent conditions such as endometriosis, breast cancer, and prostate cancer, suggesting a broader role in human health and disease.

Treatment and Research

Research into the modulation of arylsulfatase C activity offers potential therapeutic avenues for treating diseases associated with steroid metabolism. Inhibitors or activators of this enzyme could be used to regulate hormone levels in conditions where steroid hormones play a significant role. Furthermore, understanding the genetic basis of arylsulfatase C deficiency has implications for genetic counseling and the development of gene therapies for conditions like X-linked ichthyosis.

See Also

• Steroid
• Hormone
• X-linked ichthyosis
• Endometriosis
• Breast cancer
• Prostate cancer

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian